MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS
Year: 2022
Type: conference-abstract
Authors: Amy DeZern, Pierre Fenaux, Dries Deeren, Maria Diez Campelo, Michael Lübbert, Pramila Krishnamurthy, Zsolt Nagy, Grzegorz Basak, Anna Jonáš ová, Klaus Geissler, Yishai Ofran, Angela Volkert, Kristen Baker, Jaime Chisholm, Qing Kang-Fortner, David A. Roth, Michael Kelly, Giovanni Marconi
Institutions: Johns Hopkins University, Hôpital Saint-Louis, AZ Delta, Complejo Hospitalario de Salamanca, University Medical Center Freiburg, King's College Hospital, Semmelweis University, Medical University of Warsaw, General University Hospital in Prague, Klinik Hietzing, Hebrew University of Jerusalem, Shaare Zedek Medical Center, Bikur Cholim Hospital, Syros Pharmaceuticals (United States), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4296468427